MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2026-03-31.

Cash Flow Overview

Free Cash flow
-$17,770K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from the related party ...
    • Proceeds from issuance of conver...
    • Change in fair value of converti...
    • Others
Negative Cash Flow Breakdown
    • Accrued liabilities and other
    • Inventory
    • Payment of deferred offering cos...
    • Others

Cash Flow
2026-03-31
Net loss
-17,740
Depreciation and amortization
56
Share-based compensation
407
Change in fair value of convertible notes payable
-728
Change in fair value of warrant liabilities
16
Amortization of debt discount and debt issuance costs
127
Accounts receivable
419
Inventory
593
Other assets
139
Accounts payable
727
Accrued liabilities and other
-898
Net cash used in operating activities
-17,728
Purchases of property and equipment
42
Net cash used in investing activities
-42
Exercise of common stock options
358
Proceeds from issuance of convertible notes payable
14,102
Proceeds from the related party issuance of convertible notes payable
25,898
Proceeds from issuance of series f redeemable convertible preferred stock, net of issuance costs
0
Proceeds from the related party issuance of series f redeemable convertible preferred stock, net of issuance costs
0
Payment of deferred offering costs
450
Net cash provided by financing activities
39,908
Net change in cash and cash equivalents
22,138
Cash and cash equivalents, beginning of period
33,587
Cash and cash equivalents, end of period
55,725
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from the relatedparty issuance of...$25,898K Proceeds from issuance ofconvertible notes payable$14,102K Exercise of common stockoptions$358K Net cash provided byfinancing activities$39,908K Canceled cashflow$450K Net change in cashand cash...$22,138K Canceled cashflow$17,770K Payment of deferredoffering costs$450K Change in fair value ofconvertible notes payable-$728K Accounts payable$727K Share-based compensation$407K Amortization of debt discountand debt issuance...$127K Depreciation andamortization$56K Change in fair value ofwarrant liabilities$16K Net cash used inoperating activities-$17,728K Net cash used ininvesting activities-$42K Canceled cashflow$2,061K Net loss-$17,740K Purchases of property andequipment$42K Accrued liabilities andother-$898K Inventory$593K Accounts receivable$419K Other assets$139K

Mobia Medical, Inc. (MOBI)

Mobia Medical, Inc. (MOBI)